Dark Forest Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,111
Closed -$97.9K 1084
2024
Q3
$97.9K Buy
14,111
+3,078
+28% +$24.2K 0.01% 920
2024
Q2
$86.1K Buy
+11,033
New +$81.7K 0.02% 625
2023
Q4
Sell
-435,912
Closed -$2.45M 715
2023
Q3
$2.45M Buy
+435,912
New +$2.91M 0.19% 77
2023
Q1
Sell
-68
Closed -$317 1283
2022
Q4
$317 Sell
68
-50,482
-100% -$249K ﹤0.01% 1039
2022
Q3
$236K Buy
+50,550
New +$319K 0.04% 365
2022
Q2
Sell
-592
Closed -$11K 1061
2022
Q1
$11K Buy
592
+542
+1,084% +$12.4K ﹤0.01% 979
2021
Q4
$2K Sell
50
-6,008
-99% -$242K ﹤0.01% 1293
2021
Q3
$248K Buy
6,058
+5,977
+7,379% +$217K 0.09% 199
2021
Q2
$3K Buy
+81
New +$2.99K ﹤0.01% 740

Other funds holding GDRX

Dark Forest Capital Management's GDRX Position: Q4 2024 in Review

Dark Forest Capital Management sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 14,111 shares — an estimated $97.9K sold.

Dark Forest Capital Management first reported a position in GDRX in Q2 2021 and held it in 9 quarters. The position peaked at $2.45M in Q3 2023. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Dark Forest Capital Management reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Dark Forest Capital Management sold 14,111 GoodRx Holdings shares in Q4 2024, an estimated $97.9K.
  • Dark Forest Capital Management first reported a position in GoodRx Holdings in Q2 2021 and held it in 9 quarters.
  • Dark Forest Capital Management's GoodRx Holdings position peaked at $2.45M in Q3 2023.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Dark Forest Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.